Publikation: Perspective on multi-target antiplatelet therapies : high content phenotypic screening as an unbiased source of novel polypharmacological strategies
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
DOI (zitierfähiger Link)
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
Platelets play an important role in cardiovascular thrombosis as well as in many other pathological conditions such as inflammation, atherosclerosis and cancer. While multi-target strategies to treat complex diseases are gaining considerable attention, current development of antiplatelet therapies is mostly oriented towards several single targets, arising from our present understanding of the regulation of platelet activation. Limited efforts to develop multi-target agents or multidrug therapies are mostly due to a lack of a systematic basis to define target combinations with synergistic effects. Here we discuss the perspective to use high content phenotypic screening of in vitro models as a potential source for inference of synergetic multi-target strategies to control platelet activation.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
LANDRÉ, Vivien, Ivano AMELIO, Nick A. BARLEV, Richard A. KNIGHT, Andrey LISITSA, Gerry MELINO, Alexey V. ANTONOV, 2015. Perspective on multi-target antiplatelet therapies : high content phenotypic screening as an unbiased source of novel polypharmacological strategies. In: Mini reviews in medicinal chemistry. Bentham Science. 2015, 15(8), pp. 622-629. ISSN 1389-5575. eISSN 1875-5607. Available under: doi: 10.2174/1389557515666150219124018BibTex
@article{Landre2015Persp-57075, year={2015}, doi={10.2174/1389557515666150219124018}, title={Perspective on multi-target antiplatelet therapies : high content phenotypic screening as an unbiased source of novel polypharmacological strategies}, number={8}, volume={15}, issn={1389-5575}, journal={Mini reviews in medicinal chemistry}, pages={622--629}, author={Landré, Vivien and Amelio, Ivano and Barlev, Nick A. and Knight, Richard A. and Lisitsa, Andrey and Melino, Gerry and Antonov, Alexey V.} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/57075"> <dc:language>eng</dc:language> <dc:creator>Melino, Gerry</dc:creator> <dc:contributor>Lisitsa, Andrey</dc:contributor> <dc:contributor>Knight, Richard A.</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-03-30T08:54:56Z</dcterms:available> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dcterms:abstract xml:lang="eng">Platelets play an important role in cardiovascular thrombosis as well as in many other pathological conditions such as inflammation, atherosclerosis and cancer. While multi-target strategies to treat complex diseases are gaining considerable attention, current development of antiplatelet therapies is mostly oriented towards several single targets, arising from our present understanding of the regulation of platelet activation. Limited efforts to develop multi-target agents or multidrug therapies are mostly due to a lack of a systematic basis to define target combinations with synergistic effects. Here we discuss the perspective to use high content phenotypic screening of in vitro models as a potential source for inference of synergetic multi-target strategies to control platelet activation.</dcterms:abstract> <dc:creator>Knight, Richard A.</dc:creator> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-03-30T08:54:56Z</dc:date> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:creator>Lisitsa, Andrey</dc:creator> <dc:contributor>Antonov, Alexey V.</dc:contributor> <dc:contributor>Barlev, Nick A.</dc:contributor> <dc:contributor>Melino, Gerry</dc:contributor> <dc:creator>Barlev, Nick A.</dc:creator> <dc:creator>Amelio, Ivano</dc:creator> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:creator>Antonov, Alexey V.</dc:creator> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/57075"/> <dc:creator>Landré, Vivien</dc:creator> <dcterms:issued>2015</dcterms:issued> <dcterms:title>Perspective on multi-target antiplatelet therapies : high content phenotypic screening as an unbiased source of novel polypharmacological strategies</dcterms:title> <dc:contributor>Amelio, Ivano</dc:contributor> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dc:contributor>Landré, Vivien</dc:contributor> <dc:rights>terms-of-use</dc:rights> </rdf:Description> </rdf:RDF>